BioNTech SE (BNTX) Change in Acquisitions & Divestments (2021 - 2022)

BioNTech SE's (BNTX) quarterly Change in Acquisitions & Divestments came in at -$17.0 million in Q4 2022, up 23.62% year-on-year from -$13.8 million in Q4 2021, and up 45.66% quarter-over-quarter from -$31.4 million in Q3 2022.

BioNTech SE (BNTX) Change in Acquisitions & Divestments (2021 - 2022) Analysis & Trends

BioNTech SE has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting -$17.0 million for Q4 2022.

  • Change in Acquisitions & Divestments for Q4 2022 came in at -$17.0 million, up 23.62% year-over-year; the trailing twelve-month figure through Dec 2022 was -$73.9 million (changed N/A YoY), and the FY2022 annual result was -$48.8 million, down 118.62% from the prior year.
  • Change in Acquisitions & Divestments came in at -$17.0 million for Q4 2022 at BioNTech SE, up from -$31.4 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of -$3.2 million in Q2 2022 to a low of -$31.4 million in Q3 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 BioNTech SE 27.38 Bn 10.07 Bn 668.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 -17.04 Mn
Dec 31, 2022 -17.04 Mn
Sep 30, 2022 -31.36 Mn
Sep 30, 2022 -31.36 Mn
Jun 30, 2022 -3.20 Mn
Jun 30, 2022 -3.20 Mn
Dec 31, 2021 -22.31 Mn
Dec 31, 2021 -22.31 Mn